JP2023084138A5 - - Google Patents

Info

Publication number
JP2023084138A5
JP2023084138A5 JP2023069597A JP2023069597A JP2023084138A5 JP 2023084138 A5 JP2023084138 A5 JP 2023084138A5 JP 2023069597 A JP2023069597 A JP 2023069597A JP 2023069597 A JP2023069597 A JP 2023069597A JP 2023084138 A5 JP2023084138 A5 JP 2023084138A5
Authority
JP
Japan
Prior art keywords
invention described
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023069597A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023084138A (ja
Filing date
Publication date
Priority claimed from JP2022563493A external-priority patent/JP7268255B1/ja
Application filed filed Critical
Publication of JP2023084138A publication Critical patent/JP2023084138A/ja
Publication of JP2023084138A5 publication Critical patent/JP2023084138A5/ja
Pending legal-status Critical Current

Links

JP2023069597A 2021-07-21 2023-04-20 アリールアミド誘導体の製造方法 Pending JP2023084138A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021120977 2021-07-21
JP2021120977 2021-07-21
JP2022563493A JP7268255B1 (ja) 2021-07-21 2022-07-20 アリールアミド誘導体の製造方法

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2022563493A Division JP7268255B1 (ja) 2021-07-21 2022-07-20 アリールアミド誘導体の製造方法

Publications (2)

Publication Number Publication Date
JP2023084138A JP2023084138A (ja) 2023-06-16
JP2023084138A5 true JP2023084138A5 (enExample) 2025-07-30

Family

ID=84980009

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022563493A Active JP7268255B1 (ja) 2021-07-21 2022-07-20 アリールアミド誘導体の製造方法
JP2023069597A Pending JP2023084138A (ja) 2021-07-21 2023-04-20 アリールアミド誘導体の製造方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2022563493A Active JP7268255B1 (ja) 2021-07-21 2022-07-20 アリールアミド誘導体の製造方法

Country Status (12)

Country Link
US (1) US20240327355A1 (enExample)
EP (1) EP4375273A4 (enExample)
JP (2) JP7268255B1 (enExample)
KR (1) KR102671612B1 (enExample)
CN (1) CN117677607A (enExample)
AR (1) AR126517A1 (enExample)
AU (1) AU2022312992A1 (enExample)
CA (1) CA3226827A1 (enExample)
IL (1) IL310123A (enExample)
MX (1) MX2024000908A (enExample)
TW (1) TW202321198A (enExample)
WO (1) WO2023003014A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2026522033A (ja) * 2023-07-06 2026-07-03 華健未来(成都)科技股▲フン▼有限公司 芳香族アミド誘導体およびその使用
WO2025063275A1 (ja) 2023-09-21 2025-03-27 中外製薬株式会社 アリールアミド誘導体の製造方法
AU2024417154A1 (en) * 2024-01-01 2026-08-13 Huajian Future (Chengdu) Technology Co., Ltd. Aromatic hydrazide derivative and medical use thereof
CN118604164B (zh) * 2024-05-15 2025-06-06 石家庄四药有限公司 一种非奈利酮中间体中杂质的检测方法
WO2026098657A1 (zh) * 2024-11-08 2026-05-15 先声再明医药股份有限公司 作为mek抑制剂的杂环化合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4931419B2 (ja) * 2003-09-19 2012-05-16 中外製薬株式会社 新規4−フェニルアミノ−ベンズアルドオキシム誘導体並びにそのmek阻害剤としての使用
MY144232A (en) * 2004-07-26 2011-08-15 Chugai Pharmaceutical Co Ltd 5-substituted-2-phenylamino benzamides as mek inhibitors
AR059339A1 (es) 2006-02-09 2008-03-26 Chugai Pharmaceutical Co Ltd Derivados de la cumarina para trastornos proliferativos de celulas, composicion farmaceutica y agente terapeutico que los contiene
PT2344474E (pt) * 2008-09-02 2015-12-28 Novartis Ag Derivados de picolinamida como inibidores de cinase
BR112012010519A2 (pt) * 2009-11-04 2017-12-05 Novartis Ag derivados de sulfonamida heterocíclicos
JP2016034900A (ja) * 2012-11-26 2016-03-17 中外製薬株式会社 5−置換−2−フェニルアミノ−ベンズアミド類の製造方法
AR121078A1 (es) * 2020-01-22 2022-04-13 Chugai Pharmaceutical Co Ltd Derivados de arilamida con actividad antitumoral
KR20230122174A (ko) * 2020-07-22 2023-08-22 추가이 세이야쿠 가부시키가이샤 아릴 아마이드 유도체를 포함하는 조성물
WO2022018875A1 (ja) * 2020-07-22 2022-01-27 中外製薬株式会社 アリールアミド誘導体を含む細胞増殖性疾患の治療又は予防用医薬組成物

Similar Documents

Publication Publication Date Title
JP2023085489A5 (enExample)
JP2023105131A5 (enExample)
JP2021048879A5 (enExample)
JP2021151238A5 (enExample)
JP2023116721A5 (enExample)
JP2023052878A5 (enExample)
JP2022068302A5 (enExample)
JP2023526975A5 (enExample)
JP2021028398A5 (enExample)
JP2020040981A5 (enExample)
JP2020007340A5 (enExample)
JP2024026077A5 (enExample)
JP2023022224A5 (enExample)
JP2021100406A5 (enExample)
JP2022122972A5 (enExample)
JP2022185040A5 (enExample)
JP2025506484A5 (enExample)
JP2022060295A5 (enExample)
JP2023182571A5 (enExample)
JP2023133317A5 (enExample)
JP2022064180A5 (enExample)
JP2023116477A5 (enExample)
JP2020079331A5 (enExample)
JP2023011759A5 (enExample)
JP2024534771A5 (enExample)